Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 65526 - 65550 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Resveratrol	Investigational	POLA1	5422	downregulated	resveratrol results in decreased expression of POLA1 mRNA	Xp22.11-p21.3	A23857
Resveratrol	Investigational	PON1	5444	upregulated	resveratrol results in increased expression of PON1 mRNA	7q21.3	A24001 A23954
Resveratrol	Investigational	POU5F1	5460	downregulated	resveratrol results in decreased expression of POU5F1 mRNA	6p21.33	A23846 A23897
Resveratrol	Investigational	PPARA	5465	upregulated	resveratrol analog results in increased expression of PPARA mRNA	22q13.31	A21418
Resveratrol	Investigational	PPARA	5465	downregulated	resveratrol results in decreased expression of PPARA mRNA	22q13.31	A23892
Resveratrol	Investigational	PPARD	5467	upregulated	resveratrol analog results in increased expression of PPARD mRNA	6p21.31	A21418
Resveratrol	Investigational	PPARD	5467	downregulated	resveratrol results in decreased expression of PPARD mRNA	6p21.31	A22498 A23847
Resveratrol	Investigational	PPARG	5468	upregulated	resveratrol analog results in increased expression of PPARG mRNA	3p25.2	A21418
Resveratrol	Investigational	PPARG	5468	downregulated	resveratrol results in decreased expression of PPARG mRNA	3p25.2	A21627 A23879 A23892
Resveratrol	Investigational	PPARG	5468	upregulated	resveratrol results in increased expression of PPARG mRNA	3p25.2	A23843 A23856
Resveratrol	Investigational	PPARGC1A	10891	upregulated	resveratrol results in increased expression of PPARGC1A mRNA	4p15.2	A23957 A23888 A23848
Resveratrol	Investigational	PPIF	10105	upregulated	resveratrol results in increased expression of PPIF mRNA	10q22.3	A21103
Resveratrol	Investigational	PPM1A	5494	downregulated	resveratrol results in decreased expression of PPM1A mRNA	14q23.1	A23852
Resveratrol	Investigational	PPP1R2	5504	upregulated	resveratrol results in increased expression of PPP1R2 mRNA	3q29	A23858
Resveratrol	Investigational	PRDM2	7799	downregulated	resveratrol results in decreased expression of PRDM2 mRNA	1p36.21	A23847
Resveratrol	Investigational	PRF1	5551	upregulated	resveratrol results in increased expression of PRF1 mRNA	10q22.1	A23967
Resveratrol	Investigational	PRIM1	5557	downregulated	resveratrol results in decreased expression of PRIM1 mRNA	12q13.3	A23857
Resveratrol	Investigational	PRKAR2A	5576	upregulated	resveratrol results in increased expression of PRKAR2A mRNA	3p21.31	A22289
Resveratrol	Investigational	PRMT6	55170	downregulated	resveratrol results in decreased expression of PRMT6 mRNA	1p13.3	A22289
Resveratrol	Investigational	PRODH2	58510	upregulated	resveratrol results in increased expression of PRODH2 mRNA	19q13.12	A23852
Resveratrol	Investigational	PROS1	5627	downregulated	resveratrol results in decreased expression of PROS1 mRNA	3q11.1	A22789
Resveratrol	Investigational	PRRC2A	7916	upregulated	resveratrol results in increased expression of PRRC2A mRNA	6p21.33	A22498
Resveratrol	Investigational	PRSS23	11098	downregulated	resveratrol results in decreased expression of PRSS23 mRNA	11q14.2	A21103
Resveratrol	Investigational	PRY	9081	upregulated	resveratrol results in increased expression of PRY mRNA	Yq11.223	A23845
Resveratrol	Investigational	PSIP1	11168	upregulated	resveratrol results in increased expression of PSIP1 mRNA	9p22.3	A21103

Displaying entries 65526 - 65550 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability